In their study, it was demonstrated that disease risk–associated cis-eQTLs were more commonly cell type specific compared with non-disease–associated cis-eQTLs and that MS risk–associated cis-eQTLs were overrepresented in CD4 T cells. Here, CD4 is linked to myeloid sarcoma.